TXG Stock-Based Compensation

10X Genomics Inc Class A · Stock-Based Compensation

TXG logo

TXG Stock-Based Compensation

Latest reported$98.74M
TXG TTM Stock-Based Comp ($2.66M → $98.74M)
High-resolution chart · PNG

TXG stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

10X Genomics Inc Class A Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
98,741,000
100,684,000
109,118,000
116,439,000
124,763,000
135,696,000
140,749,000
147,127,000
153,774,000
160,978,000
166,950,000
169,006,000
162,285,000
152,902,000
136,848,000
122,778,000
115,214,000
105,833,000
95,962,000
83,327,000
71,161,000
58,084,000
48,626,000
39,432,000
29,522,000
18,692,000
13,333,000
9,321,000
6,036,000
3,514,000
2,658,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.